Prior Medications and the Cardiovascular Benefits From Combination Angiotensin‐Converting Enzyme Inhibition Plus Calcium Channel Blockade Among High‐Risk Hypertensive Patients

BACKGROUND: The ACCOMPLISH (Avoiding Cardiovascular Events Through Combination Therapy in Patients Living with Systolic Hypertension) trial demonstrated that combination therapy using amlodipine, rather than hydrochlorothiazide, in conjunction with benazepril provided greater cardiovascular risk red...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Am Heart Assoc
Auteurs principaux: Brook, Robert D., Kaciroti, Niko, Bakris, George, Dahlöf, Björn, Pitt, Bertram, Velazquez, Eric, Weber, Michael, Zappe, Dion H., Hau, Tsushung, Jamerson, Kenneth A.
Format: Artigo
Langue:Inglês
Publié: John Wiley and Sons Inc. 2018
Sujets:
Original Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5778960/
https://ncbi.nlm.nih.gov/pubmed/29301757
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.117.006940
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires